{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,25]],"date-time":"2025-06-25T09:54:19Z","timestamp":1750845259097,"version":"3.40.4"},"reference-count":32,"publisher":"AOSIS","issue":"1","license":[{"start":{"date-parts":[[2023,1,30]],"date-time":"2023-01-30T00:00:00Z","timestamp":1675036800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["African Journal of Primary Health Care & Family Medicine"],"DOI":"10.4102\/phcfm.v15i1.3392","type":"journal-article","created":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T08:54:19Z","timestamp":1675241659000},"source":"Crossref","is-referenced-by-count":2,"title":["Retention of service users on opioid substitution therapy in the City of Tshwane, South Africa"],"prefix":"10.4102","volume":"15","author":[{"given":"Daniela S.","family":"Goeieman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dimakatso S.","family":"Nonyane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Doudou K.","family":"Nzaumvila","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michelle N. S.","family":"Janse van Rensburg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2580","published-online":{"date-parts":[[2023,1,30]]},"reference":[{"key":"ref0","unstructured":"United Nations Office on Drugs and Crime. World drug report [homepage on the Internet]. Vienna: UNODC; c2020 [updated 2021 Jun; cited 2020 Nov 02]. Available from: https:\/\/wdr.unodc.org\/wdr2020\/index.html"},{"key":"ref1","unstructured":"Dada S. Substance abuse & drug injection trends in South Africa 13th annual TDI meeting [homepage on the Internet]. Lisbon; 2013. [cited 2020 Mar 29]. Available from: https:\/\/www.emcdda.europa.eu\/attachements.cfm\/att_230539_EN_08.%20S.%20Dada%20-%20Injection%20Trends%20in%20South%20Africa"},{"key":"ref2","unstructured":"South African Medical Research Council. South African Community Epidemiology Network on Drug Use. SACENDU report 2019 [homepage on the Internet]. c2019 [updated 2021 Dec 12"},{"key":"ref3","unstructured":"cited 2020 Mar 29]. Available from: http:\/\/www.mrc.ac.za\/intramural-research-units\/ATOD-sacendu"},{"key":"ref4","doi-asserted-by":"publisher","unstructured":"Mokwena K. 'Consider our plight': A cry for help from nyaope users. Health SA Gesondheid. 2016;21:137-142. https:\/\/doi.org\/10.1016\/j.hsag.2015.09.001","DOI":"10.1016\/j.hsag.2015.09.001"},{"key":"ref5","doi-asserted-by":"publisher","unstructured":"Strathdee SA, Hallett TB, Bobrova N, et al. HIV and risk environment for injecting drug users: The past, present, and future. Lancet. 2010;376(9737):268-284. https:\/\/doi.org\/10.1016\/S0140-6736(10)60743-X","DOI":"10.1016\/S0140-6736(10)60743-X"},{"key":"ref6","doi-asserted-by":"publisher","unstructured":"Rao R. The journey of opioid substitution therapy in India: Achievements and challenges. Indian J Psychiatry. 2017;59(1):39-45. https:\/\/doi.org\/10.4103\/psychiatry.IndianJPsychiatry_37_17","DOI":"10.4103\/psychiatry.IndianJPsychiatry_37_17"},{"key":"ref7","unstructured":"Harm Reduction International. What is harm reduction? [homepage on the Internet]. c2021 [updated 2021; cited 2020 Aug 17]. Available from: https:\/\/www.hri.global\/what-is-harm-reduction"},{"key":"ref8","unstructured":"Zinberg N. Drug, set, and setting. 1st ed. New Haven, CT: Yale University Press; 1984."},{"key":"ref9","doi-asserted-by":"publisher","unstructured":"Hartogsohn I. Constructing drug effects: A history of set and setting. Drug Sci Policy Law. 2017;3:1-17. https:\/\/doi.org\/10.1177\/2050324516683325","DOI":"10.1177\/2050324516683325"},{"key":"ref10","unstructured":"West R. Model of addiction. Luxembourg: European Monitoring Centre for Drugs and Drug Addiction; 2013."},{"key":"ref11","doi-asserted-by":"publisher","unstructured":"Scheibe A, Young K, Moses L, et al. Understanding hepatitis B, hepatitis C and HIV among people who inject drugs in South Africa: Findings from a three-city cross-sectional survey. Harm Reduct J. 2019;16(1):28. https:\/\/doi.org\/10.1186\/s12954-019-0298-2","DOI":"10.1186\/s12954-019-0298-2"},{"key":"ref12","unstructured":"South Africa. Department of Social Development. National drug master plan [homepage on the Internet]. 4th ed. 2019-2024. c2019 [cited 2020 Nov 11]. Available from: https:\/\/www.gov.za\/sites\/default\/files\/gcis_document\/202006\/drug-master-plan.pdf"},{"key":"ref13","doi-asserted-by":"publisher","unstructured":"Weich L. 'Defeating the dragon' - Can we afford not to treat patients with heroin dependence? S Afr J Psychiatr. 2010;16(3):75-79. https:\/\/doi.org\/10.4102\/sajpsychiatry.v16i3.260","DOI":"10.4102\/sajpsychiatry.v16i3.260"},{"key":"ref14","unstructured":"South African National AIDS Council. Mid-term review of the national strategic plan on HIV, TB and STIs 2017-2022 [homepage on the Internet]. SANAC; c2019 [cited 2021 Jun 05]. Available from: https:\/\/sanac.org.za\/wp-content\/uploads\/2021\/05\/NSP-MTR-Full-Report-2017-2022-FINAL.pdf"},{"key":"ref15","unstructured":"National Department of Health, South Africa. Essential drugs programme. Hospital level (Adults) standard treatment guidelines and essential medicines list. 5th ed. 2019."},{"key":"ref16","unstructured":"South African Addiction Medicine Society. South African guidelines for the management of opioid use disorders [homepage on the Internet]. c2013 [updated 2015; cited 2020 Nov 11]. Available from: https:\/\/www.saams.co.za\/OpManCourse\/Guidelines"},{"key":"ref17","unstructured":"World Health Organization. Regional Office for South-East Asia\u200e. Operational guidelines for the management of opioid dependence in the South-East Asia Region [homepage on the Internet]. WHO Regional Office for South-East Asia. c2008 [updated 2021; cited 2020 Jun 20]. Available from: https:\/\/apps.who.int\/iris\/handle\/10665\/205591"},{"key":"ref18","doi-asserted-by":"publisher","unstructured":"Singh RR, Ambekar A. Opioid substitution treatment in a public health setting: A collaboration between hospitals and NGOs in the Punjab. Int J Drug Policy. 2012;23(2):170-171. https:\/\/doi.org\/10.1016\/j.drugpo.2011.11.003","DOI":"10.1016\/j.drugpo.2011.11.003"},{"key":"ref19","doi-asserted-by":"publisher","unstructured":"Michie G, Hoosain S, Macharia M, Weich L. Report on the first government-funded opioid substitution programme for heroin users in the Western Cape Province, South Africa. S Afr Med J. 2017;107(6):539-542. https:\/\/doi.org\/10.7196\/SAMJ.2017.v107i6.12140","DOI":"10.7196\/SAMJ.2017.v107i6.12140"},{"key":"ref20","doi-asserted-by":"publisher","unstructured":"Scheibe A, Shelly S, Hugo J, et al. Harm reduction in practice - The Community Oriented Substance Use Programme in Tshwane. Afr J Prim Health Care Fam Med. 2020;12(1):e1-e6. https:\/\/doi.org\/10.4102\/phcfm.v12i1.2285","DOI":"10.4102\/phcfm.v12i1.2285"},{"key":"ref21","doi-asserted-by":"publisher","unstructured":"Gloeck NR, Harris BN, Webb EM, et al. Factors predicting 6-month retention among people with opioid use disorders accessing outpatient methadone maintenance therapy in Tshwane, South Africa. S Afr Med J. 2021;111(1):68-73. https:\/\/doi.org\/10.7196\/SAMJ.2021.v111i1.14884","DOI":"10.7196\/SAMJ.2020.v111i1.14884"},{"key":"ref22","unstructured":"Saldana J, Omasta M. Qualitative research: Analyzing life. Sage, CA: Thousand Oaks, 2018 p. 155."},{"key":"ref23","doi-asserted-by":"publisher","unstructured":"Zinberg NE, Harding WM, Apsler R. What is drug abuse? J Drug Issues. 1978;8(1): 9-35. https:\/\/doi.org\/10.1177\/002204267800800102","DOI":"10.1177\/002204267800800102"},{"key":"ref24","doi-asserted-by":"publisher","unstructured":"Attride-Stirling J. Thematic networks: An analytic tool for qualitative research. Qual Res. 2001;1(3):385-405. https:\/\/doi.org\/10.1177\/146879410100100307","DOI":"10.1177\/146879410100100307"},{"key":"ref25","doi-asserted-by":"publisher","unstructured":"Sohler NL, Weiss L, Egan JE, et al. Consumer attitudes about opioid addiction treatment: A focus group study in New York City. J Opioid Manag. 2013;9(2): 111-119. https:\/\/doi.org\/10.5055\/jom.2013.0152","DOI":"10.5055\/jom.2013.0152"},{"key":"ref26","unstructured":"World Health Organization. ATLAS of substance use disorders resources for the prevention and treatment substance use disorders (SUD) country profile: South Africa [homepage on the Internet]. Geneva: World Health Organization. c2010 [cited 2020 Nov 12]. Available from: https:\/\/www.who.int\/substance_abuse\/publications\/atlas_report\/profiles\/south_africa.pdf?ua=1"},{"key":"ref27","doi-asserted-by":"publisher","unstructured":"Saulle R, Vecchi S, Gowing L. Supervised dosing with a long-acting opioid medication in the management of opioid dependence. Cochrane Database Syst Rev. 2017;4:CD011983. https:\/\/doi.org\/10.1002\/14651858.CD011983.pub2","DOI":"10.1002\/14651858.CD011983.pub2"},{"key":"ref28","doi-asserted-by":"publisher","unstructured":"Snoek A, Levy N, Kennett J. Strong-willed but not successful: The importance of strategies in recovery from addiction. Addict Behav Rep. 2016;4:102-107. https:\/\/doi.org\/10.1016\/j.abrep.2016.09.002","DOI":"10.1016\/j.abrep.2016.09.002"},{"key":"ref29","doi-asserted-by":"publisher","unstructured":"Stone AL, Becker LG, Huber AM, Catalano RF. Review of risk and protective factors of substance use and problem use in emerging adulthood. Addict Behav. 2012;37(7):747-775. https:\/\/doi.org\/10.1016\/j.addbeh.2012.02.014","DOI":"10.1016\/j.addbeh.2012.02.014"},{"key":"ref30","doi-asserted-by":"publisher","unstructured":"Marks M, Scheibe A, Shelly S. High retention in an opioid agonist therapy project in Durban, South Africa: The role of best practice and social cohesion. Harm Reduct J. 2020;17(1):25. https:\/\/doi.org\/10.1186\/s12954-020-00368-1","DOI":"10.1186\/s12954-020-00368-1"},{"key":"ref31","doi-asserted-by":"publisher","unstructured":"Scheibe A, Marks M, Shelly S, Gerardy T, Domingo AK, Hugo J. Developing an advocacy agenda for increasing access to opioid substitution therapy as part of comprehensive services for people who use drugs in South Africa. S Afr Med J. 2018;108(10):800-802. https:\/\/doi.org\/10.7196\/SAMJ.2018.v108i10.13397","DOI":"10.7196\/SAMJ.2018.v108i10.13397"}],"container-title":["African Journal of Primary Health Care & Family Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/phcfm.org\/index.php\/phcfm\/article\/viewFile\/3392\/6013","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/phcfm.org\/index.php\/phcfm\/article\/viewFile\/3392\/6014","content-type":"application\/epub+zip","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/phcfm.org\/index.php\/phcfm\/article\/viewFile\/3392\/6015","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/phcfm.org\/index.php\/phcfm\/article\/viewFile\/3392\/6016","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/phcfm.org\/index.php\/phcfm\/article\/viewFile\/3392\/6016","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,15]],"date-time":"2025-04-15T11:56:04Z","timestamp":1744718164000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.phcfm.org\/index.php\/PHCFM\/article\/view\/3392"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,30]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,1,30]]}},"URL":"https:\/\/doi.org\/10.4102\/phcfm.v15i1.3392","relation":{},"ISSN":["2071-2936","2071-2928"],"issn-type":[{"type":"electronic","value":"2071-2936"},{"type":"print","value":"2071-2928"}],"subject":[],"published":{"date-parts":[[2023,1,30]]}}}